Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors
67%
Central Nervous System
51%
Nervous System Diseases
18%
Cognition Disorders
15%
Stroke
13%
3-hydroxy-3-methylglutaryl-coenzyme A
12%
Primary Prevention
10%
Dyslipidemias
9%
Secondary Prevention
9%
Oxidoreductases
9%
Multiple Sclerosis
8%
Neurodegenerative Diseases
8%
Epilepsy
8%
Cognition
7%
Pharmacokinetics
7%
Myocardial Infarction
7%
Cardiovascular Diseases
7%
Pharmacology
6%
Depression
6%
Neoplasms
3%
Therapeutics
1%
Physics & Astronomy
central nervous system
97%
strokes
46%
coenzymes
22%
disorders
21%
epilepsy
20%
cognition
20%
inhibitors
16%
cancer
12%
Engineering & Materials Science
Neurology
81%
Coenzymes
43%
Oxidoreductases
34%
Neurodegenerative diseases
34%
Pharmacokinetics
32%
Chemical Compounds
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Neurological Effect
21%
Disorder
19%
Pharmacological Effect
14%
Coenzyme A
14%
Pharmacokinetics
8%